Constipation is a rare complication of phaeochromocytomas (Short & Padfield 1976) and has been attributed to the secretion of catecholamines by large tumours (Cruz & Colwell 1972) . We report the management of a patient with severe constipation due to a malignant phaeochromocytoma. This complication proved to be the most difficult aspect of her treatment and ultimately caused her death.
Case report A 52-year-old woman was admitted to hospital with an 8-month history of widespread skeletal pain involving, the hips, elbows, knees, face and especially her spine. More recently she. had noticed palpitation.s, Raynaud's phenomenon, weight loss and heavy sweating. She had sinus tachycardia and her blood pressure varied between 120/75 and 240/140 mmHg. There were retinal haemorrhages and exudates. The diagnosis of phaeochromocytoma was confirmed with a urinary total metanephrine excretion of 250 mmol/24 hours (normal 4.5). Multiple venous sampling revealed marked elevation of noradrenaline levels from all veins between the subclavian and the common iliac, with no localized increase in level. Further evidence that the tumour was widespread and malignant was provided by radiographs which showed skeletal metastases; their distribution was confirmed by 1131 meta-iodobenzylguanidine scan as reported previously (Sutton et al. 1982) . Treatment with phenoxybenzamine 40 mg daily and propranolol 160 mg daily controlled the cardiovascular phenomena, and buprenorphine was given for the skeletal pain.
At the time of her first admission she reported having only two bowel actions each week and faecal matter was palpable in the descending colon. Enemas, including the disposable, soap and water, and olive oil retention types, were never effective but at first some relief of the constipation was obtained with 1 litre of 10% mannitol given by mouth. Four months after the diagnosis was first made she was readmitted with a history of eight days constipation, severe abdominal pain and tympanitic distension. Abdominal radiographs showed the colon to be dilated by gas and faeces. From this time until her death, constipation became her major problem,; attempts to control it were as follows: Day I Admitted with 8 days constipation taking phenoxybenzamine 40 mg and propranolol 160 mg daily. Buprenorphine 1 mg daily with diconal supplements were required for pain relief. 3 Mannitol 1 litre 10% by mouth produced a little unformed stool. 6 Metoclopramide 40 mg daily; no effect. 7 Pentazocine 250mg daily with indomethacin and aspirin were given, and other analgesics were stopped.
i1 Phentolamine 60 mg intravenously given over 4 hours; no effect. 13 Phentolamine 180 mg intravenously given over 50 minutes. Immediate passage of flatus and stool, her blood pressure dropped briefly during the infusion and she vomited once. Afterwards her abdomen was less distended. The phenoxybenzamine dosage was increased to a total of 480 mg daily by day 42, but there was no spontaneous defaecation during this time. 37 Phentolamine 180 mg intravenously given over 'Accepted 12 October 1983 0141-0768/84/040327-02/$01.00/0 20 minutes caused considerable vomiting and passage of some flatus and stool. 44 Phentolamine 180 mg intravenously given over 45 minutes again produced vomiting and passage of flatus and stool. Neostigmine 60mg then 120 mg daily by mouth with prazosin 1.5 mg daily were given and daily spontaneous defaecation was reestablished. 62 Prazosin and metoclopramide were withdrawn, but regular defaecation continued.
The improvement was maintained for a further month but she became steadily weaker as the neoplasm extended. Eventually she developed features of cholinergic overdosage (nausea, miosis, salivation, borborygmi and frequent stools) and the dose of neostigmine was reduced. Seven days later she was again distended and constipated and the previous dose of neostigmine failed to correct this problem. Over the following seven weeks she remained distended and a further infusion of phentolamine, with the addition of metoclopramide 40 mg and prazosin 3 mg rising to 12 mg daily, did not ease the problem. Finally she developed severe abdominal pain and a plain radiograph revealed gas under the diaphragm. At laparotomy a perforation was found at the rectosigmoid junction and a transverse colostomy was performed, but the patient died soon after surgery.
Discussion
The intestine has both a sympathetic innervation which causes reduced motility and sphincter contraction, and a parasympathetic (cholinergic) innervation which has the opposite effects (Mayer 1980) . We consider that our patient's constipation was primarily the result of excess circulating sympathomimetic catecholamines, rather than the effects of the opiates and other analgesics she was given for pain. Large doses of the alphaadrenoceptor blocking agent phentolamine given intravenously temporarily relieved the constipation but caused unpleasant vomiting. Oral adrenoceptor blocking agents were insufficient to relieve the constipation until a cholinergic drug was added. This restored spontaneous defaecation for a period of six weeks, during which time the opiates were prescribed at their previous dose without adverse effect.
We suggest that the combination of a cholinergic drug with alpha-adrenoceptor blocking agents should be considered in the management of other patients with phaeochromocytomas and constipation unresponsive to adrenoceptor blockade alone.
